盐酸氨溴索加盐酸丙卡特罗在小儿肺炎的临床效果评价
|
摘要
目的评价盐酸氨溴索加盐酸丙卡特罗在小儿肺炎治疗中的效果。方法随机抽调医院收治的肺炎患儿70例分为两组,对照组35例采用常规治疗,观察组35例实施盐酸氨溴索加盐酸丙卡特罗治疗,比较不同方法治疗效果。结果观察组治疗后总有效率、症状改善时间(退热时间、咳嗽消退时间、喘息消停时间)、肺功能水平(FEV1、FVC、FEV1/FVC)与对照组相比,差异有统计学意义(P<0.05)。结论盐酸氨溴索加盐酸丙卡特罗治疗小儿肺炎,疗效确切显著。
Objective To evaluate the efficacy of ambroxol hydrochloride plus procaterol hydrochloride in the treatment of children with pneumonia. Methods 70 patients with pneumonia admitted at hospital were randomly divided into two groups. 35 patients in the control group were treated with conventional therapy. 35 patients in the observation group were treated with ambroxol hydrochloride and procaterol hydrochloride. The effects of different methods were compared. Results The total effective rate, symptom improvement time(epitothermic time, cough remission time, wheezing arrest time) and pulmonary function(FEV1, FVC, FEV1/FVC) in the observation group were statistically significant compared with the control group(P < 0.05). Conclusion Ambroxol hydrochloride plus procaterol hydrochloride is effective in the treatment of children with pneumonia.
Objective To evaluate the efficacy of ambroxol hydrochloride plus procaterol hydrochloride in the treatment of children with pneumonia. Methods 70 patients with pneumonia admitted at hospital were randomly divided into two groups. 35 patients in the control group were treated with conventional therapy. 35 patients in the observation group were treated with ambroxol hydrochloride and procaterol hydrochloride. The effects of different methods were compared. Results The total effective rate, symptom improvement time(epitothermic time, cough remission time, wheezing arrest time) and pulmonary function(FEV1, FVC, FEV1/FVC) in the observation group were statistically significant compared with the control group(P < 0.05). Conclusion Ambroxol hydrochloride plus procaterol hydrochloride is effective in the treatment of children with pneumonia.
引文
[1]余强,袁浩宇.小儿肺热咳喘口服液联合阿奇霉素治疗小儿肺炎支原体肺炎43例[J].中国药业,2016,25(4):121-122.
[2]潘锁良.常规疗法与布地奈德雾化吸入法治疗小儿肺炎的随机对照研究[J].中国实用医刊,2016,43(3):117-118.
[3]谢辉.阿奇霉素联合脂溶性维生素治疗小儿肺炎支原体肺炎的临床观察[J].重庆医学,2016,45(8):1151-1152.
[4]池卫明,廖华.系统评价盐酸氨溴索注射液静脉滴注联合雾化吸入治疗新生儿肺炎的疗效和安全性[J].中国药房,2016,27(3):341-344.
[5]黄华波.新生儿肺炎治疗中抗生素的应用及时间效应分析[J].当代医学,2016,22(2):130-131.
[6]王浩.不同抗生素治疗新生儿肺炎的疗效与安全性分析[J].中国卫生标准管理,2016,7(17):120-122.
[7]胡德飞,罗孝华,钟世冰.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效评价[J].基层医学论坛,2016,20(36):5087-5088.
[8]刘启洁,钱涪屏,曾丽娜,等.经鼻持续气道正压通气治疗重症新生儿肺炎效果观察[J].现代诊断与治疗,2016,27(6):981-983.
[9]邢艳敏,李沛珊,刘莹.经鼻持续气道正压通气治疗新生儿肺炎40例的临床效果评价[J].继续医学教育,2016,30(6):100-101.
[10]范于娥.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的临床效果探讨[J].医学理论与实践,2016,29(7):935-936.
[11]高杰.丙种球蛋白辅助治疗新生儿肺炎的疗效及对免疫功能的影响[J].中国妇幼保健,2016,31(7):1451-1453.
[12]曲轶.探讨小儿肺炎支原体肺炎的临床治疗效果[J].中国卫生标准管理,2017,8(23):86-87.
[13]郑香顺.采用雾化吸入联合静脉注射的方式用沐舒坦治疗新生儿肺炎的效果观察[J].当代医药论丛,2016,14(17):37-38.
[2]潘锁良.常规疗法与布地奈德雾化吸入法治疗小儿肺炎的随机对照研究[J].中国实用医刊,2016,43(3):117-118.
[3]谢辉.阿奇霉素联合脂溶性维生素治疗小儿肺炎支原体肺炎的临床观察[J].重庆医学,2016,45(8):1151-1152.
[4]池卫明,廖华.系统评价盐酸氨溴索注射液静脉滴注联合雾化吸入治疗新生儿肺炎的疗效和安全性[J].中国药房,2016,27(3):341-344.
[5]黄华波.新生儿肺炎治疗中抗生素的应用及时间效应分析[J].当代医学,2016,22(2):130-131.
[6]王浩.不同抗生素治疗新生儿肺炎的疗效与安全性分析[J].中国卫生标准管理,2016,7(17):120-122.
[7]胡德飞,罗孝华,钟世冰.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效评价[J].基层医学论坛,2016,20(36):5087-5088.
[8]刘启洁,钱涪屏,曾丽娜,等.经鼻持续气道正压通气治疗重症新生儿肺炎效果观察[J].现代诊断与治疗,2016,27(6):981-983.
[9]邢艳敏,李沛珊,刘莹.经鼻持续气道正压通气治疗新生儿肺炎40例的临床效果评价[J].继续医学教育,2016,30(6):100-101.
[10]范于娥.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的临床效果探讨[J].医学理论与实践,2016,29(7):935-936.
[11]高杰.丙种球蛋白辅助治疗新生儿肺炎的疗效及对免疫功能的影响[J].中国妇幼保健,2016,31(7):1451-1453.
[12]曲轶.探讨小儿肺炎支原体肺炎的临床治疗效果[J].中国卫生标准管理,2017,8(23):86-87.
[13]郑香顺.采用雾化吸入联合静脉注射的方式用沐舒坦治疗新生儿肺炎的效果观察[J].当代医药论丛,2016,14(17):37-38.